Advertisement
Screener

Akcea Therapeutics, Inc. Capital Expenditures

Akcea Therapeutics, Inc. Capital Expenditures

Akcea Therapeutics, Inc. reported Capital Expenditures of $558.00 thousand for the 6-month period ending 2020-06-30, per its 10-Q filed 2020-08-05.

Discontinued › Cash Flow › Investing Activities

us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2020-08-05

  • Akcea Therapeutics, Inc. payments to acquire property, plant, and equipment for the quarter ending 2020-06-30 was $349.00K, a 2.51% decline year-over-year.
  • Akcea Therapeutics, Inc. payments to acquire property, plant, and equipment for the quarter ending 2020-03-31 was $209.00K, a 79.73% decline year-over-year.
  • Akcea Therapeutics, Inc. payments to acquire property, plant, and equipment for the quarter ending 2019-12-31 was $178.00K, a 82.25% decline year-over-year.
  • Akcea Therapeutics, Inc. payments to acquire property, plant, and equipment for the quarter ending 2019-09-30 was $29.00K, a 73.87% decline year-over-year.
  • Akcea Therapeutics, Inc. payments to acquire property, plant, and equipment for fiscal 2019 was $1.60M, a 42.63% increase from fiscal 2018.
  • Akcea Therapeutics, Inc. payments to acquire property, plant, and equipment for fiscal 2018 was $1.12M, a 12333.33% increase from fiscal 2017.
  • Akcea Therapeutics, Inc. payments to acquire property, plant, and equipment for fiscal 2017 was $9.00K, a 94.97% decline from fiscal 2016.
  • Akcea Therapeutics, Inc. payments to acquire property, plant, and equipment for fiscal 2016 was $179.00K.
Period endPayments to Acquire Property, Plant, and Equipment 3 monthPayments to Acquire Property, Plant, and Equipment 6 monthPayments to Acquire Property, Plant, and Equipment 9 monthPayments to Acquire Property, Plant, and Equipment 12 month
2020-06-30$349.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05
$558.00K
10-Q · filed 2020-08-05
$736.00K
derived: sum of 3 quarters · filed 2020-08-05
$765.00K
derived: sum of 4 quarters · filed 2020-08-05
2020-03-31$209.00K
10-Q · filed 2020-05-06
$387.00K
derived: sum of 2 quarters · filed 2020-05-06
$416.00K
derived: sum of 3 quarters · filed 2020-05-06
$774.00K
derived: sum of 4 quarters · filed 2020-08-05
2019-12-31$178.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02
$207.00K
derived: sum of 2 quarters · filed 2020-03-02
$565.00K
derived: sum of 3 quarters · filed 2020-08-05
$1.60M
10-K · filed 2020-03-02
2019-09-30$29.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06
$387.00K
derived: sum of 2 quarters · filed 2020-08-05
$1.42M
10-Q · filed 2019-11-06
$2.42M
derived: sum of 4 quarters · filed 2020-08-05
2019-06-30$358.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05
$1.39M
10-Q · filed 2020-08-05
$2.39M
derived: sum of 3 quarters · filed 2020-08-05
$2.50M
derived: sum of 4 quarters · filed 2020-08-05
2019-03-31$1.03M
10-Q · filed 2020-05-06
$2.03M
derived: sum of 2 quarters · filed 2020-05-06
$2.15M
derived: sum of 3 quarters · filed 2020-05-06
2018-12-31$1.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02
$1.11M
derived: sum of 2 quarters · filed 2020-03-02
$1.12M
10-K · filed 2020-03-02
2018-09-30$111.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06
$116.00K
10-Q · filed 2019-11-06
2018-06-30$5.00K
10-Q · filed 2019-08-07
2017-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02
$9.00K
derived: sum of 2 quarters · filed 2020-03-02
$9.00K
10-K · filed 2020-03-02
2017-09-30$9.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06
$9.00K
10-Q · filed 2018-11-06
2017-06-30$0.00
10-Q · filed 2018-08-07
2016-12-31$121.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01
$134.00K
derived: sum of 2 quarters · filed 2019-03-01
$179.00K
10-K · filed 2019-03-01
2016-09-30$13.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07
$58.00K
10-Q · filed 2017-11-07
2016-06-30$45.00K
10-Q · filed 2017-08-09
2015-12-31$10.00K
8-K · filed 2018-09-18